Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 115 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
1141 10.4 months Transitional Cell Carcinoma 4 Chemotherapy
Chao Family Comprehensive Cancer Center, University of California Irvine United States 7/2013
Treatment Details: Patients: This phase 2 study involved 18 transitional cell bladder cancer patients. The median patient age was 71.5 years and 10 were male. Treatment: Patients were treated with the ch
 
1142 10.3 months Transitional cell carcinoma of the urothelium 5 Chemotherapy
Aarhus University Hospital Denmark 10/2006
Treatment Details: Patients: This phase II study involved 64 patients with transitional cell carcinoma of the urothelium. The median patient age was 65 years and 83% were male. Treatment: Patients were t
 
1143 10.3 months Urothelial cancer 4 Chemotherapy
Kitasato University Hospital Japan 11/2007
Treatment Details: Patients: This study included 10 male urothelial cancer (of the bladder and upper urinary tract) patients who had previously been treated with methotrexate, vinblastine, adriamycin, and cis
 
1144 10.3 months Platinum/taxane-refractory and -resistant ovarian cancer 4 Chemotherapy
Kurume University Japan 2/2013
Treatment Details: Patients: This phase 2 study involved 32 women with ovarian cancer that had progressed after prior platinum-and/or taxane-based chemotherapy. The average patient age was 53.6 years. Tre
 
1145 10.3 months Advanced NSCLC 4 Biologic therapy
Chemotherapy
Eli Lilly and Company United States 5/2006
Treatment Details: Patients: This Phase II trial involved a total of 53 patients with advanced non-small-cell lung cancer. There were 35 men and 18 women and the median age was 67. Twenty-seven patients had
 
1146 10.3 months metastatic breast cancer 4 Chemotherapy
Mayo Clinic and Foundation United States 2/2006
Treatment Details: Patients: This Phase II study involved 59 women with metastatic breast cancer. The median age was 51 years. Three patients were African-American, one was Asian, and the rest were Caucasian
 
1147 10.3 months Ovarian cancer 3 Biologic therapy
Massachusetts General Hospital United States 11/2006
Treatment Details: Patients: This phase II trial enrolled and treated 37 women with recurrent platinum-resistant ovarian cancer. The average age was 58 years, ranging from 28 to 83. Treatment: Patients w
 
1148 10.3 months GBM 5 Chemotherapy
Radiation
Sidney Kimmel Comprehensive Cancer Center United States 11/2006
Treatment Details: Patients: This Phase II single arm study involved 55 patients with newly diagnosed glioblastoma multiforme. 60% were men, and the age range was from 31-79.4 years. 87% had resective surge
 
1149 10.3 months Malignant peritoneal mesothelioma 5 Chemotherapy
Cardarelli Hospital Italy 5/2009
Treatment Details: Patients: This study involved 109 patients with malignant peritoneal mesothelioma. The median age was 59.8, ranging from 24 to 79 years of age. The majority (66.1%) were men. About half h
 
1150 10.3 months NSCLC 5 Chemotherapy
Osaka City General Hospital Japan 1/2009
Treatment Details: Patients: This phase 3 study involved 130 patients with non-small cell lung cancer who had previously been treated with a platinum-based chemotherapy. They ranged in age from 34 to 75 years
 
Page 115 of 187  | Previous Page  | Next Page